Effect of an Electronic Alert on Risk of Contrast-Induced Acute Kidney Injury in Hospitalized Patients Undergoing Computed Tomography

被引:46
作者
Cho, AJin [1 ]
Lee, Jung Eun [1 ]
Yoon, Jae Young [1 ]
Jang, Hye Ryoun [1 ]
Huh, Wooseong [1 ]
Kim, Yoon-Goo [1 ]
Kim, Dae Joong [1 ]
Oh, Ha Young [1 ]
机构
[1] Sungkyunkwan Univ, Sch Med, Div Nephrol, Samsung Med Ctr,Dept Med, Seoul 135710, South Korea
关键词
Contrast-induced nephropathy; prophylaxis; electronic alert; PERCUTANEOUS CORONARY INTERVENTION; INDUCED NEPHROPATHY; N-ACETYLCYSTEINE; ORDER ENTRY; PREVENTION; TRIAL; HYDRATION; OUTCOMES; DISEASE; EVENTS;
D O I
10.1053/j.ajkd.2012.02.331
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Prophylaxis against contrast-induced acute kidney injury (AKI) in hospitalized patients is underused. We evaluated the impact of a computerized alert program for contrast-induced AKI for hospitalized patients undergoing contrast-enhanced computed tomography (CT). Study Design: Quality improvement report. Setting & Participants: 463 adult inpatients in a single center with estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m(2). Quality Improvement Plan: We developed a computer alert program in which the responsible physician was alerted to a patient's risk of contrast-induced AKI in the form of a warning message box and was recommended to consider prophylactic measures for contrast-induced AKI when he or she ordered contrast-enhanced CT for patients with eGFR <60 mL/min/1.73 m(2). The intervention was applied simultaneously to all hospitalized patients from March 18, 2010. The hospital's contrast-induced AKI preventive guidelines included prehydration, posthydration, and oral N-acetylcysteine. Outcome & Measurements: Use of prophylactic interventions, development of contrast-induced AKI. Contrast-induced AKI was defined as an increase in serum creatinine level (>= 0.3 mg/dL or >= 50%) 24-72 hours after contrast medium exposure. Results: 258 adult inpatients with eGFR <60 mL/min/1.73 m(2) were identified as undergoing contrast-enhanced CT before application of the computer alert program (from October 28, 2009, to March 17, 2010), and 205, after its application (from March 18, 2010, to August 5, 2010). Individuals in the postalert group received contrast-induced AKI prophylaxis more often than those in the prealert group (55% vs 25% for total prophylaxis; P < 0.001). The incidence of contrast-induced AKI was lower in the postalert group than in the prealert group (3% vs 10%; P = 0.02). Limitations: Observation bias; only 61.5% of participants were evaluated for contrast-induced AKI. Conclusions: Implementation of a computerized alert program in hospitalized patients was followed by increased use of prophylaxis and decreased risk of contrast-induced AKI. Am J Kidney Dis. 60(1):74-81. (C) 2012 by the National Kidney Foundation, Inc.
引用
收藏
页码:74 / 81
页数:8
相关论文
共 41 条
  • [1] Intravenous N-Acetylcysteine in the Prevention of Contrast Media-Induced Nephropathy
    Anderson, Spencer M.
    Park, Zoon H.
    Patel, Ramesh V.
    [J]. ANNALS OF PHARMACOTHERAPY, 2011, 45 (01) : 101 - 107
  • [2] Preventing nephropathy induced by contrast medium
    Barrett, BJ
    Parfrey, PS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (04) : 379 - 386
  • [3] Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography - A double-blind comparison of iodixanol and iopamidol
    Barrett, Brendan J.
    Katzberg, Richard W.
    Thomsen, Henrik S.
    Chen, Nan
    Sahani, Dushyant
    Soulez, Gilles
    Heiken, Jay P.
    Lepanto, Luigi
    Ni, Zhou-Hui
    Nelson, Rendon
    [J]. INVESTIGATIVE RADIOLOGY, 2006, 41 (11) : 815 - 821
  • [4] Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification
    Bartholomew, BA
    Harjai, KJ
    Dukkipati, S
    Boura, JA
    Yerkey, MW
    Glazier, S
    Grines, CL
    O'Neill, WW
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (12) : 1515 - 1519
  • [5] Patient safety: Improving safety with information technology
    Bates, DW
    Gawande, AA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (25) : 2526 - 2534
  • [6] Acetylcysteine for Prevention of Renal Outcomes in Patients Undergoing Coronary and Peripheral Vascular Angiography Main Results From the Randomized Acetylcysteine for Contrast-Induced Nephropathy Trial (ACT)
    Berwanger, Otavio
    Cavalcanti, Alexandre B.
    Sousa, Amanda G. M. R.
    Buehler, Anna M.
    Kodama, Alessandra A.
    Carballo, Mariana T.
    Carvalho, Vitor O.
    Amodeo, Celso
    Lotaif, Leda D.
    Sousa, Jose Eduardo
    Victor, Elivane S.
    Santucci, Eliana
    Cardoso, Carlos E. S.
    da Silva, Dalmo
    Mendes, Adailton L.
    Lobato, Jose
    Prates, G.
    Yokoyama, H.
    Almeida, P.
    Pessoa, C.
    Martins, H.
    Lopes, M.
    Barros, M.
    Reis, H.
    Cordeiro, C.
    Castello, H.
    Cantarelli, M.
    Ferreira, S.
    Mattos, C.
    Rati, M.
    Medeiros, C.
    Mangione, J. A.
    Mauro, M. F.
    Cristovao, S. A.
    Carnieto, N. M.
    Rocha, L. C.
    Maksud, D. F.
    Barbosa, C.
    Costantini, C.
    Tarbine, S.
    Santos, M.
    Ortiz, C.
    Souza, A.
    Mattos, C.
    Duarte, L.
    Marin Neto, J.
    Figueiredo, G.
    Lemos, D.
    Braga, F.
    Novaes, G.
    [J]. CIRCULATION, 2011, 124 (11) : 1250 - 1259
  • [7] The epidemiology of prescribing errors - The potential impact of computerized prescriber order entry
    Bobb, A
    Gleason, K
    Husch, M
    Feinglass, J
    Yarnold, PR
    Noskin, GA
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (07) : 785 - 792
  • [8] How do centres begin the process to prevent contrast-induced acute kidney injury: a report from a new regional collaborative
    Brown, Jeremiah R.
    McCullough, Peter A.
    Splaine, Mark E.
    Davies, Louise
    Ross, Cathy S.
    Dauerman, Harold L.
    Robb, John F.
    Boss, Richard
    Goldberg, David J.
    Fedele, Frank A.
    Kellett, Mirle A.
    Phillips, William J.
    Lee, Peter N. Ver
    Nelson, Eugene C.
    MacKenzie, Todd A.
    O'Connor, Gerald T.
    Sarnak, Mark J.
    Malenka, David J.
    [J]. BMJ QUALITY & SAFETY, 2012, 21 (01) : 54 - 62
  • [9] Guided medication dosing for inpatients with renal insufficiency
    Chertow, GM
    Lee, J
    Kuperman, GJ
    Burdick, E
    Horsky, J
    Seger, DL
    Lee, R
    Mekala, A
    Song, J
    Komaroff, AL
    Bates, DW
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (22): : 2839 - 2844
  • [10] Rationale, design, and baseline characteristics of the Acetylcystein for Contrast-Induced nephropaThy (ACT) Trial: a pragmatic randomized controlled trial to evaluate the efficacy of acetylcysteine for the prevention of contrast-induced nephropathy
    Costa, Eduardo
    Reis, Helder
    de Assis, Gabriela M. C. C.
    Cardoso, Gracilene L.
    Barbosa, Marcio M.
    de Aguiar Filho, Francisco A. A.
    Gama, Carlos A. V.
    Silva, Marcelo Goes A.
    Aguiar, Bruno M.
    Ferreira, Marcelo G.
    Feitosa, Gilson S.
    Victor Filho, Edgard
    Rocha, Emmanuel B. D.
    Paiva, Maria S. M. O.
    Czochra, Eliana R.
    Oliveira, Ludmila A. R. R.
    de Oliveira, Itamar R.
    Pinheiro, Flavia
    Dourado, Gilvan O.
    Luna Filho, Antonio L.
    Pacheco, Amilson
    Nunes, Paulo M. S.
    de Sa Filho, Alcino P.
    Martins, Helman C.
    Lopes, Marcelo A. C.
    Barros, Marco A. V.
    Mattos, Claudia
    Neves, Miguel A.
    Medeiros, Cesar Rocha
    Duarte, Leonardo
    Cramer, Helena
    Santos, Braulio, Jr.
    Tura, Bernardo R.
    Rodrigues, Cyro V.
    Terreiro, Luis A. O.
    Alves, Monica A.
    Soares, Jamil S.
    da Cunha, Cristiane C.
    da Silva, Antonio C. B.
    Barcelos, Alexandre M.
    Teixeira, Marco A.
    Pinto, Joselena S.
    Saad, Jamil A.
    Mandil, Ari
    Falcheto, Eduardo
    Areas, Carlos Augusto F.
    Dall'Orto, Frederico T. C.
    Freitas, Ivan F.
    Botelho, Roberto V.
    Seabra, Miriam D. G.
    [J]. TRIALS, 2009, 10